Short answer
Standard drug tests do not screen for CBD. The 5-panel urine test used by most US employers looks for THC, cocaine, opiates, amphetamines, and phencyclidine. CBD is not on that list.
The test looks for 11-nor-9-carboxy-THC, a metabolite the body makes after THC enters the blood. CBD does not break down into that compound.
Can CBD Trigger a Drug Screen? What Actually Matters
Where the risk comes from
Hemp-derived CBD products can contain THC. Federal law sets the limit at 0.3% THC by dry weight for hemp. Full-spectrum CBD keeps other plant compounds, and THC is one of them.
Small amounts add up. Daily use of a full-spectrum tincture or vape can deliver enough THC to push a urine sample over the cutoff. The common immunoassay cutoff is 50 ng/mL.
Label accuracy
Lab studies of CBD products sold online and in stores found THC content that did not match the label. Some products marked THC-free contained THC. Others contained less CBD than stated.
CBD isolate is the lowest-risk form. Isolate is purified CBD with THC removed to trace levels.
Detection windows
- Single low THC dose: 1 to 3 days in urine
- Daily use: 1 to 3 weeks
- Heavy long-term use: up to 30 days, and longer in some cases
- Hair test: up to 90 days
- Blood test: hours to a few days
Prescription CBD
Epidiolex is a prescription CBD drug for seizures. Some patients on high doses have reported positive screens. The evidence is mixed. The FDA label does not list a positive drug test as a known effect.
Cross-reactivity and false positives
Immunoassays can react with compounds that have a similar shape. Reports exist of CBD metabolites triggering a positive at high concentrations. Labs confirm any positive with GC-MS or LC-MS/MS before reporting it.
What lowers the odds
- Buy CBD isolate, not full-spectrum
- Ask for a batch certificate of analysis with THC results
- Avoid daily high doses
- Stop full-spectrum use at least 30 days before a test that matters
No method removes all risk. Labels vary, lab reports vary, and cutoffs vary by testing lab.